- Home
- TARA vs NUTX Comparison
TARA vs NUTX Comparison
Compare TARA & NUTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- NUTX
- Stock Information
- Founded
- TARA N/A
- NUTX 2011
- Country
- TARA United States
- NUTX United States
- Employees
- TARA N/A
- NUTX N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- NUTX Retail: Computer Software & Peripheral Equipment
- Sector
- TARA Health Care
- NUTX Technology
- Exchange
- TARA Nasdaq
- NUTX Nasdaq
- Market Cap
- TARA 202.8M
- NUTX 182.2M
- IPO Year
- TARA N/A
- NUTX N/A
- Fundamental
- Price
- TARA $4.55
- NUTX $37.81
- Analyst Decision
- TARA Strong Buy
- NUTX Strong Buy
- Analyst Count
- TARA 3
- NUTX 2
- Target Price
- TARA $22.67
- NUTX $55.00
- AVG Volume (30 Days)
- TARA 523.2K
- NUTX 25.0K
- Earning Date
- TARA 03-12-2025
- NUTX 11-07-2024
- Dividend Yield
- TARA N/A
- NUTX N/A
- EPS Growth
- TARA N/A
- NUTX N/A
- EPS
- TARA N/A
- NUTX N/A
- Revenue
- TARA N/A
- NUTX $292,000,390.00
- Revenue This Year
- TARA N/A
- NUTX $25.00
- Revenue Next Year
- TARA N/A
- NUTX $14.40
- P/E Ratio
- TARA N/A
- NUTX N/A
- Revenue Growth
- TARA N/A
- NUTX 26.02
- 52 Week Low
- TARA $1.60
- NUTX $4.16
- 52 Week High
- TARA $10.48
- NUTX $41.44
- Technical
- Relative Strength Index (RSI)
- TARA 41.78
- NUTX 63.48
- Support Level
- TARA $5.04
- NUTX $28.82
- Resistance Level
- TARA $6.20
- NUTX $35.94
- Average True Range (ATR)
- TARA 0.40
- NUTX 2.18
- MACD
- TARA -0.22
- NUTX 0.47
- Stochastic Oscillator
- TARA 2.37
- NUTX 77.57
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About NUTX Nutex Health Inc.
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.